Literature DB >> 19247661

The many faces of scleroderma sine scleroderma: a literature review focusing on cardiopulmonary complications.

Sophie P Toya1, George E Tzelepis.   

Abstract

Scleroderma sine scleroderma (ssSSc) is an occult form of systemic sclerosis that may cause diagnostic difficulties due to the absence of skin involvement. Delays in the diagnosis of ssSSc means lost opportunites to address and treat the often lethal involvement of internal organs such as the lungs and heart. In this systemic review we collected all published cases of ssSSc using EMBASE, MEDLINE, PubMed, and Web of Science from 1950 to present. Our purpose was to describe the range and frequency of the clinical manifestations of ssSSc. A total of 108 published cases of ssSSc were analyzed. Lung involvement was present in 66% of cases. Peripheral vascular system involvement was present in all patients whereas gastrointestinal manifestations were present in 82% of the cases. Overall the clinical presentation is subtle and heightened clinical awareness is required to facilitate prompt recognition and treatment.

Entities:  

Mesh:

Year:  2009        PMID: 19247661     DOI: 10.1007/s00296-009-0878-7

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  46 in total

1.  Scleroderma renal crisis sine scleroderma.

Authors:  Joan-Josep Canet; Josep Castañé; Manuel Alvarez; Juan-Manuel Nava; Joan Llibre
Journal:  Nephron       Date:  2002-01       Impact factor: 2.847

2.  Systemic sclerosis and antineutrophil cytoplasmic autoantibody-associated renal failure.

Authors:  A Katrib; A Sturgess; J V Bertouch
Journal:  Rheumatol Int       Date:  1999       Impact factor: 2.631

3.  Scleroderma of the lungs.

Authors:  R D MILLER; W S FOWLER; F H HELMHOLZ
Journal:  Proc Staff Meet Mayo Clin       Date:  1959-02-04

4.  Visceral scleroderma without skin involvement.

Authors:  S CROWN
Journal:  Br Med J       Date:  1961-12-09

5.  Progressive systemic sclerosis sine scleroderma.

Authors:  G P RODNAN; R H FENNELL
Journal:  JAMA       Date:  1962-05-26       Impact factor: 56.272

6.  Are isolated antinucleolar antibodies a marker of scleroderma?

Authors:  Meenakshi Jolly; Mary Smaron; Tammy Olsen Utset; Michael Ellman
Journal:  J Clin Rheumatol       Date:  2003-10       Impact factor: 3.517

7.  Anti-RNA polymerase III antibodies in the diagnosis of scleroderma renal crisis sine scleroderma.

Authors:  T G Phan; A Cass; A Gillin; P Trew; N Fertig; A Sturgess
Journal:  J Rheumatol       Date:  1999-11       Impact factor: 4.666

8.  [Interstitial pneumonitis as a clinical manifestation in a patient with systemic sclerosis without scleroderma].

Authors:  P Cubo Romano; P Mínguez García; S Muñoz Albarrán; M Abad Cardiel; J C Pontes Navarro
Journal:  An Med Interna       Date:  2005-08

9.  Outcomes in primary Raynaud phenomenon: a meta-analysis of the frequency, rates, and predictors of transition to secondary diseases.

Authors:  G Spencer-Green
Journal:  Arch Intern Med       Date:  1998-03-23

Review 10.  ANCA-related crescentic glomerulonephritis in a patient with scleroderma without marked dermatological change and malignant hypertension.

Authors:  Mai Tomioka; Fumihiko Hinoshita; Naoko Miyauchi; Yurika Akiyama; Shigeki Saima; Michiaki Hiroe
Journal:  Intern Med       Date:  2004-06       Impact factor: 1.271

View more
  12 in total

1.  Systemic sclerosis sine scleroderma associated with antiphospholipid syndrome.

Authors:  Pollyanna d'Ávila Leite; Jozélio Freire de Carvalho
Journal:  Rheumatol Int       Date:  2010-04-09       Impact factor: 2.631

Review 2.  Lung involvement in systemic sclerosis.

Authors:  Paul M Hassoun
Journal:  Presse Med       Date:  2010-12-30       Impact factor: 1.228

Review 3.  Interstitial lung disease in systemic sclerosis: current and future treatment.

Authors:  Roberto Giacomelli; Vasiliki Liakouli; Onorina Berardicurti; Piero Ruscitti; Paola Di Benedetto; Francesco Carubbi; Giuliana Guggino; Salvatore Di Bartolomeo; Francesco Ciccia; Giovanni Triolo; Paola Cipriani
Journal:  Rheumatol Int       Date:  2017-01-06       Impact factor: 2.631

Review 4.  The promising role of lung ultrasound in systemic sclerosis.

Authors:  A Delle Sedie; L Carli; E Cioffi; S Bombardieri; L Riente
Journal:  Clin Rheumatol       Date:  2012-07-29       Impact factor: 2.980

Review 5.  [The road to early diagnosis of systemic sclerosis : the evolution of diagnostic and classification criteria in the past decades].

Authors:  M Frerix; F M P Meier; U Müller-Ladner
Journal:  Z Rheumatol       Date:  2013-12       Impact factor: 1.372

6.  Significance of serum uric acid in pulmonary hypertension due to systemic sclerosis: a pilot study.

Authors:  Theodoros Dimitroulas; Georgios Giannakoulas; Hariklia Dimitroula; Tilemahos Sfetsios; Despina Parcharidou; Haralambos Karvounis; Loukas Settas
Journal:  Rheumatol Int       Date:  2010-07-25       Impact factor: 2.631

Review 7.  Scleroderma lung disease.

Authors:  Joshua J Solomon; Amy L Olson; Aryeh Fischer; Todd Bull; Kevin K Brown; Ganesh Raghu
Journal:  Eur Respir Rev       Date:  2013-03-01

8.  Scleroderma lung disease.

Authors:  Jérôme Le Pavec; David Launay; Stephen C Mathai; Paul M Hassoun; Marc Humbert
Journal:  Clin Rev Allergy Immunol       Date:  2011-04       Impact factor: 8.667

9.  Acute fibrinous and organizing pneumonia and undifferentiated connective tissue disease: a case report.

Authors:  Valéria Valim; Roberta Hora Rocha; Roberta Barcelos Couto; Thaysa Simões Paixão; Erica Vieira Serrano
Journal:  Case Rep Rheumatol       Date:  2012-04-04

10.  A case of sine scleroderma with parenchymal lung disease.

Authors:  Mansoor Karimifar; Hourosadat Hashemi; Mozhgan Karimifar; Amir Kazizadeh
Journal:  Adv Biomed Res       Date:  2014-01-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.